ECOG-ACRIN EA6134  Ipilimumab + Nivolumab vs. Dabrafenib + Trametinib

ECOG-ACRIN EA6134 Ipilimumab + Nivolumab vs. Dabrafenib + Trametinib

Annual-Meeting

1 year
111 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ahmad Tarhini, MD, PhD, Cleveland Clinic Main Campus, talks about ECOG-ACRIN EA6134 Ipilimumab + Nivolumab vs. Dabrafenib + Trametinib at Annual Meeting 2018
Up Next Autoplay